ID

27362

Descripción

Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate CRF Seiten: 934-977

Palabras clave

Versiones (2)
  1. 9/11/17 9/11/17 -
  2. 26/11/17 26/11/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

9 de noviembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Previous Clinical Trial Participation GSK study Prostatic neoplasms NCT00883909

Inglés

Previous Clinical Trial Participation GSK study Prostatic neoplasms NCT00883909

1 formularios  
Administrative data
Descripción

Administrative data

Session number
Descripción

Session number

Tipo de datos

integer

Subject number
Descripción

Subject number

Tipo de datos

text

Previous Clinical Trial Participation
Descripción

Previous Clinical Trial Participation

Date of REDUCE 4 Year Contact
Descripción

The REDUCE 4 Year Contact is either: a) a REDUCE 4 Year clinic visit for subjects on treatment (Visit 10), or b) a REDUCE 4 Year clinic visit for subjects in Prostate Cancer Follow-Up (Visit 10P), or c) a 4 Year phone call for subjects in Phone Follow-Up

Tipo de datos

date

Date Investigational Product Stopped
Descripción

Date Investigational Product Stopped

Tipo de datos

date

Was the subject previously diagnosed with prostate cancer during the REDUCE (ARI40006) study?
Descripción

previous diagnosis of prostate cancer

Tipo de datos

text

If YES, record the date of the biopsy resulting in prostate cancer diagnosis
Descripción

date of the biopsy

Tipo de datos

date

Volver a la parte superior de la página

Similar models

Previous Clinical Trial Participation GSK study Prostatic neoplasms NCT00883909

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative data
Session number
Item
Session number
integer
Subject number
Item
Subject number
text
Item Group
Previous Clinical Trial Participation
Date of REDUCE 4 Year Contact
Item
Date of REDUCE 4 Year Contact
date
Date Investigational Product Stopped
Item
Date Investigational Product Stopped
date
Item
Was the subject previously diagnosed with prostate cancer during the REDUCE (ARI40006) study?
text
previous diagnosis of prostate cancer
Code List
Was the subject previously diagnosed with prostate cancer during the REDUCE (ARI40006) study?
CL Item
Yes (Y)
CL Item
No (N)
date of the biopsy
Item
If YES, record the date of the biopsy resulting in prostate cancer diagnosis
date
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial